CVE-2019-25723: Dräger Perseus A500 Medibus DoS Vulnerability – CVSS 4.0 Analysis & Mitigation

Technical summary

The vulnerability stems from improper input handling on the Medibus interface of the Perseus A500. The Medibus protocol is a standardized industrial interface for medical devices; however, versions 2.00–2.02 fail to validate or properly constrain input from non-Medibus-compliant data streams. An unauthenticated network attacker can craft specific malformed packets that overwhelm the device's internal processor, triggering a warm restart. During this restart cycle, the ventilator transitions to an ambient-pressure state, interrupting active ventilation therapy. The attack requires network access to the Medibus port but does not require authentication, credentials, or user interaction. Recovery is automatic once the restart completes, but the interruption itself poses clinical risk. The vulnerability is catalogued under CWE-1286 (Improper Validation of Specified Quantity in Input).

Business impact

For healthcare organizations operating Dräger Perseus A500 ventilators, this vulnerability introduces unplanned therapy interruption risk. A successful attack would temporarily halt ventilation support for affected patients, potentially requiring manual intervention or fallback to backup equipment. Clinical outcomes depend on patient acuity and dwell time without support; even a few seconds can be clinically significant for critically ill patients. Operationally, repeated attacks could erode staff confidence in device reliability and trigger alert fatigue. The vulnerability also complicates network segmentation strategies, as medical device networks must balance isolation with interoperability. Organizations using affected software versions face a compliance and risk-management obligation to remediate or implement compensating controls.

Affected systems

Dräger Perseus A500 ventilators with software versions 2.00, 2.01, and 2.02 are vulnerable. The Medibus interface is the attack surface; systems must be reachable over a network to be exploitable. Any clinical care setting using these specific software builds—including intensive care units, operating rooms, and respiratory care units—is in scope. Organizations should inventory deployed devices and confirm software version through device management interfaces or Dräger's asset management tools.

Exploitability

Exploitability is rated medium-to-high in practical terms. The attack vector is network-based with no authentication or user interaction required, lowering the barrier to entry. However, the attack requires precise crafting of non-Medibus-compliant packets; a generic port scan or standard network traffic will not trigger the vulnerability. An attacker would need some familiarity with Medibus protocol structure or access to proof-of-concept code. The CVSS score of 4.0 (Medium, CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:N/A:L) reflects the network vector but also accounts for the attack complexity and localized impact. Critically, this vulnerability is not tracked in CISA's Known Exploited Vulnerabilities (KEV) catalog, suggesting no widespread active exploitation as of the published date—though the lack of KEV listing does not mean exploitation is impossible.

Remediation

Organizations should apply software updates from Dräger to versions beyond 2.02 as soon as clinically feasible. Contact Dräger technical support to obtain patched firmware and verify compatibility with your device configuration. In the interim, implement network-level mitigations: restrict Medibus interface access to authorized medical IT systems only, deploy network segmentation to isolate ventilator networks, and monitor Medibus traffic for anomalies. Additionally, ensure backup manual ventilation equipment is readily available and staff are trained on fallback procedures should device failure occur. Verify that any IDS/IPS or network monitoring tool can detect malformed Medibus traffic.

Patch guidance

Verify the current software version on deployed Perseus A500 devices. Contact Dräger technical support or consult your device asset management system for available patches. Dräger has responsibility for releasing patched versions above 2.02; prioritize upgrading to the earliest available patched build. Test patches in a non-clinical environment first to confirm compatibility with your EMR integrations and ventilator settings. Schedule firmware updates during planned maintenance windows to minimize clinical disruption. Document patch deployment dates and versions for compliance auditing.

Detection guidance

Monitor Medibus interface traffic for malformed or non-compliant data packets. Network-based IDS/IPS tools should flag attempts to send crafted payloads to the Medibus port. Enable verbose logging on ventilator devices if supported by firmware. Track unexplained warm restarts or pressure drops recorded in device event logs; correlate these with network traffic anomalies. Implement baseline profiling of normal Medibus communication to establish a reference for anomaly detection. If your organization uses a medical device network monitoring platform, configure alerting for Medibus protocol violations.

Why prioritize this

Despite a CVSS score of 4.0, this vulnerability warrants prompt attention because (1) it affects life-critical medical devices where even brief therapy interruption poses clinical harm, (2) attack complexity is moderate, meaning a determined adversary with modest Medibus knowledge can exploit it, (3) the attack surface is network-accessible, not requiring physical access, (4) affected software versions remain in active use in many healthcare settings, and (5) mitigation options are constrained by the need to maintain device functionality. Prioritize this in the context of your medical device risk program, not solely by CVSS score.

Risk score, explained

The CVSS 3.1 vector AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:N/A:L yields a base score of 4.0 (Medium). Network accessibility and the lack of privilege or user interaction requirements drive the score higher, but attack complexity (AC:H) reflects the need to craft non-Medibus-compliant packets precisely. The scope is changed (S:C) because the vulnerability can disrupt device operation affecting connected systems and patients. Confidentiality and integrity are not impacted (C:N, I:N), but availability is degraded (A:L), corresponding to temporary ventilation interruption. In clinical risk terms, this score may understate actual harm; a brief ventilation loss for a critically ill patient could have severe consequences. Use CVSS as a baseline, not the final arbiter of clinical risk.

Frequently asked questions